PROGRAM
This program may be subject to changes
Tuesday 17th : Council meeting
15:00
-
20:00
Registration
17:00
-
18:30
Executive Committee Meeting
18:30
-
19:30
Council Meeting
20:00
-
20:30
President's Dinner
Wednesday 18th
08:00
-
19:00
Registration
08:45
-
09:00
President's Welcome Speech
M. Shirmer : President of ISBD
Z. Tazi Mezalek : Presidente of the conference
M. Adnaoui : President of Moroccan Society of Internal Medicine
09:00
-
09:45
Special Lecture Netosis in auto-inflammation
Chairman : M. Shirmer (Austria), M. Adnaoui (Morocco)
P. Hasler
(Switzerland)
09:45
-
11:15
Scientific Session 1: Basic Science
Chairman : M. Shirmer (Austria), M. Adnaoui (Morocco)
09:45
-
10:05
Immunopathogenesis of Behçet’s disease
PM. Van Hagen
(Holland)
10:05
-
10:25
NET’s in Behçet’s disease
A. LeJoncour
(France)
10:25
-
10:45
Microbiome and microbes in Behçet’s disease
A. Bettiol
(Italy)
10:45
-
11:15
Oral communication
11:15
-
11:45
Coffee Break
11:45
-
13:15
Scientific Session 2: Epidemiology & Genetics
Chairman : L. Guillevin (France), H. El Kabli (Morocco)
11:45
-
12:05
Epidemiologic and genetic contribution to the phenotype of Behçet’s disease
A. Gul
(Turkey)
12:05
-
12:25
Registries in Behçet’s disease
L. Cantarini
(Italy)
12:25
-
12:45
Pathogenesis of non-infectious uveitis elucidated by recent findings
P. Haris
(UK)
12:45
-
13:15
Oral presentations
13:15
-
14:30
Lunch
14:30
-
16:00
Scientific Session 3: Ocular Disease
Chairman : A. Moutaoukil (Morocco), D. Saadoun (France)
14:30
-
14:50
What is and what is not ocular Behçet’s disease
M. Khairallah
(Tunisia)
14:50
-
15:10
Evaluation of activity in ocular Behçet’s disease
B. Bodagui
(France)
15:10
-
15:30
Treatment of ocular Behçet’s disease in 2024
I. Tugal-Tutkun
(Turkey)
15:30
-
16:00
Oral presentations
16:00
-
16:30
Coffee Break
16:30
-
18:00
Scientific Session 4: Neurologic Disease
Chairman : B. Weschler (France), F. Belahcen (Morocco)
16:30
-
16:50
Neurological involvement by Behçet’s syndrome: clinical features, diagnosis.
D. Kidd
(UK)
16:50
-
17:10
Treatment and outcome in neuro-Behçet
D. Saadoun
(France)
17:10
-
17:30
Unmet needs in neuro-Behçet
D. Kidd
(UK)
17:30
-
18:15
Oral presentation
08:15
-
19:00
Symposium
19:00
-
19:30
General assembly
19:30
Welcome Cocktail
Thursday 19th
07:45
-
08:45
Meet the expert:clinical cases of
Neurological : F. Belahcen (Morocco), B. Wechsler (France)
Ocular : O. Berbich (Morocco), B. Bodagui (France)
Vascular : Z. Tazi Mezalek (Morocco), G. Emmi
Mucocutaneous : C. Zouboulis, N. Ismaili (Morocco)
Articular : L. Essaadouni (Morocco), J. Van Lars
09:00
-
09:45
Special Opening Lecture
Chairman : D. Haskard (UK), Z. Tazi Mezalek (Morocco)
From Behçet’s disease to canker sores: the genetic architecture of autoinflammation
D. Kastner
(USA)
09:45
-
11:15
Scientific Session 5: Vascular Behçet
Chairman : Z. Tazi Mezalek (Morocco), P. Cacoub (France)
09:45
-
10:05
Clinical vascular phenotype
G. Emmi
(Italy)
10:05
-
10:25
Treatment of vascular disease
G. Hatemi
(Turkey)
10:25
-
10:45
Pulmonary and cardiac Behcet’s disease
E. Seyahi
(Turkey)
10:45
-
10:55
Assessment of asymptomatic vascular disease with imaging in Behcet's: controversial issues
H. Direskeneli
(Turkey)
10:45
-
11:15
Oral communication
11:15
-
11:45
Coffee Break
11:45
-
13:15
Scientific Session 6: Muco-cutaneous and articular Behçet’s disease
Chairman : F. Allali (Morocco), A. Altenburg (Germany)
11:45
-
12:05
Skin lesions in Adamantiades Behcet’s disease
C. Zouboulis
(Germany)
12:05
-
12:25
Oral health in Behçet’s disease
F. Fortune
(UK)
12:25
-
12:45
Gastrointestinal manifestations of Behçet’s disease: diagnosis and treatment
JH. Cheon
(Korea)
12:45
-
13:05
Musculoskeletal disorders: what is and what is not Behçet's disease
K. Echchilali
(Morocco)
13:05
-
13:30
Oral communication
13:15
-
14:30
Lunch
14:30
-
16:00
Scientific Session 7 - Diagnosis and outcomes in Behçet’s disease
Chairman : K. Bouayad (Morocco), M. Smiti (Tunisia)
14:30
-
14:50
Classification or diagnostic criteria in Behçet’s disease?
F. Alibaz
(Turkey)
14:50
-
15:10
Paediatric Behçet’s disease: diagnosis and classification
I. Kone-Pau
(France)
15:10
-
15:30
Developing outcome measures in Behcet’s disease
Y. Yazici
(USA)
15:30
-
15:50
Treat to target objective in Behcet’s disease. Is it realistic?
G. Hatemi
(Turkey)
15:30
-
16:00
Oral Presentation
16:00
-
16:45
Symposium
16:45
-
17:00
Coffee Break
17:00
-
18:30
Poster tour
19:30
Diner
Friday 20th
09:00
-
18:00
International Patient's Conference - Marrakech 2024
07:45
-
08:45
Meet The experts : clinical cases
Neurologic : K. Serraj (Morocco), M. Smiti (Tunisia)
Ocular : H. Harmouche (Morocco), M. Khairallah (Tunisia)
Vascular : B. Lekehel (Morocco), P. Cacoub (France)
Mucocutaneous : M. Bourkia (Morocco), A. Altenburg (Germany)
Gastroenterology : JH. Cheon (Korea), M. Benazzouz (Morocco)
Pediatrics : K. Bouayad (Morocco), I. Kone-Pau (France)
Articular : L. Cantarini (Italy), FZ. Alaoui (Morocco)
09:00
-
09:45
Special Lecture : Behcet's diseace in 2030
A. Gul
(Turkey)
Chairmain : F. Fortune (UK), FZ. Alaoui (Morocco)
09:45
-
11:15
Scientific Session 8: Old drugs/new drugs in BD
Chairman : N. Hajjaj Hassouni (Morocco), G. Emmi (Italy)
09:45
-
10:05
Is there still a place for immunosuppressant’s in Behçet’s disease
Y. Yazici
(USA)
10:05
-
10:25
Anti-TNF alpha, the new “corticosteroids” in Behçet’s disease ?
P. Sfikakis
(Greece)
10:25
-
10:45
Interleukins and anti-interleukins in Behçet’s disease
J. Van Lars
(Holland)
10:45
-
11:15
oral communication
11:15
-
12:00
Symposium : From colchicin to Apremilast in Behcet’s disease
12:00
Closure of the 20th ICBD, welcome to the 21th ICBD